'A little bitty spot and i'm a big man': Patients' perspectives on refusing diagnosis or treatment for lung cancer

Psycho-Oncology

Volumn 14, Issue 8, 2005, Pages 636-646

  Sharf, Barbara F ^a   Stelljes, Linda A ^b   Gordon, Howard S ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Coping; Decision making rationale; Lung neoplasms; Patient acceptance of health care; Physician patient relationship; Problematic integration; Treatment refusal; Uncertainty

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; COPING BEHAVIOR; DECISION MAKING; DOCTOR PATIENT RELATION; HEALTH CARE SYSTEM; HUMAN; ILLNESS BEHAVIOR; INTERVIEW; LUNG CANCER; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; REFUSAL TO PARTICIPATE; SOCIAL SUPPORT; TREATMENT REFUSAL;

ADAPTATION, PSYCHOLOGICAL; ATTITUDE TO HEALTH; BEHAVIOR; DECISION MAKING; DENIAL (PSYCHOLOGY); HUMANS; INTERVIEW, PSYCHOLOGICAL; LUNG NEOPLASMS; MALE; PHYSICIAN-PATIENT RELATIONS; TREATMENT REFUSAL;

EID: 23744467462     PISSN: 10579249     EISSN: None     Source Type: Journal    
DOI: 10.1002/pon.885     Document Type: Article

References (30)

1. Babrow AS. 1992. Communication and problematic integration: understanding diverging probability and value, ambiguity, ambivalence, and impossibility. Commun Theory 2: 95-130.
2. Babrow AS, Hines SC, Kasch CR. 2000. Managing uncertainty in illness explanation: An application of problematic integration theory. In Explaining Illness: Research, Theory, and Strategies, Whaley BB (ed.). Lawrence Erlbaum Associates: Mahwah, NJ; 41-67.
3. Bach PB, Cramer LD, Warren JL, Begg CB. 1999. Racial differences in the treatment of early stage lung cancer. N Engl J Med 341: 1198-1205.
4. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. 2002. Survival of blacks and whites after a cancer diagnosis. JAMA 287: 2106-2113.
5. Braddock III CH, Edwards KA, Hasenberg NM, Laidley TL, Levinson W. 1999. Informed decision making in outpatient practice: time to get back to basics. JAMA 282: 2313-2320.
6. Bramstedt KA, Arroliga AC. 2004. On the dilemma of enigmatic refusal of life-saving therapy. Chest 126: 630-633.
7. Brock DW, Wartman SA. 1990. When competent patients make irrational choices. N Engl J Med 322: 1595-1599.
8. Charmaz K. 2000. Grounded theory: objectivist and constructivist methods. In Handbook of Qualitative Research (2nd edn.), Denzin NK, Lincoln YS (eds). Sage Publications: Thousand Oaks, CA; 509-535.
9. Cullen MH, Billingham LJ, Woodroffe CM et al. 1999. Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life. J Clin Oncol 17: 3188-3194.
10. Glaser BG, Strauss AL. 1999. The Discovery of Grounded Theory; Strategies for Qualitative Research. Aldine de Gruyter: New York.
11. Green MR. 2004. Targeting targeted therapy. N Engl J Med 350: 2191-2193.
12. Greenwald HP, Polissar NL, Borgatta EF, McCorkle R, Goodman G. 1998. Social factors, treatment, and survival in early-stage non-small cell lung cancer. Am J Public Health 88: 1681-1684.
13. Haynes RB, Taylor DW, Sackett DL. 1979. Compliance in Health Care. Johns Hopkins University Press: Baltimore.
14. Huijer M, van Leeuwen E. 2000. Personal values and cancer treatment refusal. J Med Ethics 26:358-362.
15. Janz NK, Becker MH. 1984. The health belief model: A decade later. Health Educ Q 1: 1-47.
16. Jonsen AR, Sekar N, Winslade WJ. 1998. Clinical Ethics (4th edn.). McGraw-Hill: New York.
17. Lynch TJ, Bell DW, Sordella R et al. 2004. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350: 2129-2139.
18. Mahoney T, Kuo YH, Topilow A, Davis JM. 2000. Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients. Arch Surg 135: 182-185.
19. Miller K. 2002. Communication Theories: Perspectives, Processes, and Contexts. McGraw-Hill: Boston.
20. Moore PJ, Sickel AE, Malat J, Williams D, Jackson J, Adler NE. 2004. Psychosocial factors in medical and psychological treatment avoidance: the role of the doctor-patient relationship. J Health Psychol 9: 421-433.
21. Non-small Cell Lung Cancer Collaborative Group. 1995. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311: 899.
22. Partridge AH, Wang PS, Winer EP, Avorn J. 2003. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 21: 602-606.
23. Penman DT, Holland JC, Bahna GF et al. 1984. Informed consent for investigational chemotherapy: patients' and physicians' perceptions. J Clin Oncol 2: 849-855.
24. Rosenstock IM, Strecher VJ, Becker MH. 1988. Social learning theory and the Health Belief Model. Health Educ Q 15: 175-183.
25. Sieber WJ, Kaplan RM. 2000. Informed adherence: The need for shared medical decision making. Control Clin Trials 21: 233S-240S.
26. Smith TJ, Penberthy L, Desch CE et al. 1995. Differences in initial treatment patterns and outcomes of lung cancer in the elderly. Lung Cancer 13: 235-252.
27. Street RL Jr. 2001. Active patients as powerful communicators. In The New Handbook of Language and Social Psychology, Robinson WP, Giles H (eds). Wiley: New York; 541-560.
28. van Kleffens T, van Baarsen B, van Leeuwen E. 2004. The medical practice of patient autonomy and cancer treatment refusals: a patients' and physicians' perspective. Soc Sci Med 58: 2325-2336.
29. Velanovich V, Gabel M, Walker EM et al. 2002. Causes for the undertreatment of elderly breast cancer patients: tailoring treatments to individual patients. J Am Coll Surg 194: 8-13.
30. Whooley MA, Avins AL, Miranda J, Browner WS. 1997. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 12: 439-445.